Aline Beckenkamp

524 total citations
20 papers, 435 citations indexed

About

Aline Beckenkamp is a scholar working on Molecular Biology, Biomaterials and Oncology. According to data from OpenAlex, Aline Beckenkamp has authored 20 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Biomaterials and 6 papers in Oncology. Recurrent topics in Aline Beckenkamp's work include Nanoparticle-Based Drug Delivery (7 papers), Peptidase Inhibition and Analysis (4 papers) and Adenosine and Purinergic Signaling (3 papers). Aline Beckenkamp is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), Peptidase Inhibition and Analysis (4 papers) and Adenosine and Purinergic Signaling (3 papers). Aline Beckenkamp collaborates with scholars based in Brazil, South Africa and Canada. Aline Beckenkamp's co-authors include Andréia Buffon, Sı́lvia Stanisçuaski Guterres, Adriana Raffin Pohlmann, Gilsane Lino von Poser, Ruy Carlos Ruver Beck, Alessandra Nejar Bruno, Márcia Camponogara Fontana, Luiz F. Zerbini, Juliano D. Paccez and Márcia Vignoli-Silva and has published in prestigious journals such as PLoS ONE, Molecular Biology of the Cell and Journal of Ethnopharmacology.

In The Last Decade

Aline Beckenkamp

20 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aline Beckenkamp Brazil 13 170 108 81 51 45 20 435
Anvar Soleimani Iran 12 236 1.4× 114 1.1× 51 0.6× 54 1.1× 13 0.3× 22 536
Satabdi Datta India 11 177 1.0× 48 0.4× 41 0.5× 19 0.4× 20 0.4× 13 408
Xiaoqi Jiang Germany 10 238 1.4× 124 1.1× 142 1.8× 9 0.2× 56 1.2× 19 802
Sara Nikoofal‐Sahlabadi Iran 12 177 1.0× 60 0.6× 147 1.8× 9 0.2× 15 0.3× 16 475
Vladimíra Svobodová Pavlíčková Czechia 12 201 1.2× 61 0.6× 57 0.7× 8 0.2× 19 0.4× 23 420
Pan Ma China 16 293 1.7× 165 1.5× 158 2.0× 6 0.1× 7 0.2× 30 753
Chunhui Yang China 13 280 1.6× 50 0.5× 45 0.6× 20 0.4× 7 0.2× 30 451
Aiswarya Chaudhuri India 15 313 1.8× 72 0.7× 167 2.1× 6 0.1× 12 0.3× 28 626
Wanle Hu China 15 219 1.3× 149 1.4× 42 0.5× 6 0.1× 12 0.3× 22 508

Countries citing papers authored by Aline Beckenkamp

Since Specialization
Citations

This map shows the geographic impact of Aline Beckenkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aline Beckenkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aline Beckenkamp more than expected).

Fields of papers citing papers by Aline Beckenkamp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aline Beckenkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aline Beckenkamp. The network helps show where Aline Beckenkamp may publish in the future.

Co-authorship network of co-authors of Aline Beckenkamp

This figure shows the co-authorship network connecting the top 25 collaborators of Aline Beckenkamp. A scholar is included among the top collaborators of Aline Beckenkamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aline Beckenkamp. Aline Beckenkamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beckenkamp, Aline, Liziane Raquel Beckenkamp, Jean Sévigny, et al.. (2020). Imatinib mesylate affects extracellular ATP catabolism and expression of NTPDases in a chronic myeloid leukemia cell line. Purinergic Signalling. 16(1). 29–40. 10 indexed citations
2.
Beckenkamp, Aline, et al.. (2019). Phloroglucinol derivatives from Hypericum species induce in vitro proliferation of cells involved in the wound healing process. Natural Product Research. 35(22). 4648–4652. 4 indexed citations
3.
Beckenkamp, Aline, et al.. (2018). Enhanced and Selective Antiproliferative Activity of Methotrexate-Functionalized-Nanocapsules to Human Breast Cancer Cells (MCF-7). Nanomaterials. 8(1). 24–24. 23 indexed citations
4.
Beckenkamp, Aline, et al.. (2018). Antineoplastic potential of the aqueous crude extract of Eugenia uniflora L. in human cervical cancer. Brazilian Journal of Pharmaceutical Sciences. 54(2). 3 indexed citations
5.
Beckenkamp, Aline, Adriana Raffin Pohlmann, Sı́lvia Stanisçuaski Guterres, et al.. (2017). Doxazosin nanoencapsulation improves its in vitro antiproliferative and anticlonogenic effects on breast cancer cells. Biomedicine & Pharmacotherapy. 94. 10–20. 10 indexed citations
6.
Beckenkamp, Aline, et al.. (2017). Liquid formulation containing doxorubicin-loaded lipid-core nanocapsules: Cytotoxicity in human breast cancer cell line and in vitro uptake mechanism. Materials Science and Engineering C. 76. 374–382. 21 indexed citations
7.
Beckenkamp, Aline, Andréia Buffon, Marli Luiza Tebaldi, et al.. (2017). Data of PCL-b-P(MMA-DMAEMA) 2 characterization and related assays. Data in Brief. 15. 111–126. 3 indexed citations
8.
9.
Beckenkamp, Aline, Andréia Buffon, Marli Luiza Tebaldi, et al.. (2017). PCL- b -P(MMA- co -DMAEMA) 2 new triblock copolymer for novel pH-sensitive nanocapsules intended for drug delivery to tumors. Reactive and Functional Polymers. 119. 116–124. 7 indexed citations
10.
Fachel, Flávia Nathiely Silveira, et al.. (2017). Soybeans isoflavone aglycone-rich extracts: Optimization by different bioprocesses and production of a purified fraction with promising wound healing property. Industrial Crops and Products. 105. 193–202. 13 indexed citations
11.
Oliveira, Catiúscia Padilha de, Vladimir Lavayen, Aline Beckenkamp, et al.. (2016). Bromelain-Functionalized Multiple-Wall Lipid-Core Nanocapsules: Formulation, Chemical Structure and Antiproliferative Effect Against Human Breast Cancer Cells (MCF-7). Pharmaceutical Research. 34(2). 438–452. 31 indexed citations
12.
Beckenkamp, Aline, et al.. (2016). DPPIV/CD26: a tumor suppressor or a marker of malignancy?. Tumor Biology. 37(6). 7059–7073. 51 indexed citations
13.
14.
Beckenkamp, Aline, Juliano D. Paccez, Luiz F. Zerbini, et al.. (2015). Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells. PLoS ONE. 10(7). e0134305–e0134305. 36 indexed citations
15.
Beckenkamp, Aline, et al.. (2015). CD26 a cancer stem cell marker and therapeutic target. Biomedicine & Pharmacotherapy. 71. 135–138. 42 indexed citations
16.
Beckenkamp, Aline, et al.. (2015). Proliferative effect of plants used for wound healing in Rio Grande do Sul state, Brazil. Journal of Ethnopharmacology. 176. 305–310. 35 indexed citations
17.
Beck, Ruy Carlos Ruver, Márcia Camponogara Fontana, Aline Beckenkamp, & Andréia Buffon. (2014). Controlled release of raloxifene by nanoencapsulation: effect on in vitro antiproliferative activity of human breast cancer cells. International Journal of Nanomedicine. 9. 2979–2979. 36 indexed citations
18.
Beckenkamp, Aline, Alessandra Nejar Bruno, Émerson André Casali, et al.. (2014). Ectonucleotidase expression profile and activity in human cervical cancer cell lines. Biochemistry and Cell Biology. 92(2). 95–104. 13 indexed citations
19.
Mello, Paola de Andrade, Eduardo Cremonese Filippi‐Chiela, Aline Beckenkamp, et al.. (2014). Adenosine uptake is the major effector of extracellular ATP toxicity in human cervical cancer cells. Molecular Biology of the Cell. 25(19). 2905–2918. 53 indexed citations
20.
Buffon, Andréia, Aline Beckenkamp, Juliano D. Paccez, et al.. (2013). Abstract A43: Investigation of dipeptidyl peptidase IV/CD26 role in cervical cancer cell lines.. Molecular Cancer Therapeutics. 12(11_Supplement). A43–A43. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anvar Soleimani Breakdown of academic impact, for papers by Satabdi Datta Breakdown of academic impact, for papers by Xiaoqi Jiang Breakdown of academic impact, for papers by Sara Nikoofal‐Sahlabadi Breakdown of academic impact, for papers by Vladimíra Svobodová Pavlíčková Breakdown of academic impact, for papers by Pan Ma Breakdown of academic impact, for papers by Chunhui Yang Breakdown of academic impact, for papers by Aiswarya Chaudhuri Breakdown of academic impact, for papers by Wanle Hu
Rankless by CCL
2026